Upregulation of Wilms' tumor gene 1 (WT1) in desmoid tumors

International Journal of Cancer

Volumn 114, Issue 2, 2005, Pages 202-208

  Nik, Saeid Amini ^a   Hohenstein, Peter ^b   Jadidizadeh, Ali ^a   Van Dam, Kim ^a   Bastidas, Adriana ^a   Berry, Rachel L ^b   Patek, Charles E ^b   Van Der Schueren, Bernadette ^a   Cassiman, Jean Jacques ^a   Tejpar, Sabine ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

catenin; Aggressive fibromatosis; Desmoid tumor; Wnt pathway; WT1

Indexed keywords

BETA CATENIN; WNT PROTEIN; ZINC FINGER PROTEIN;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; DESMOID TUMOR; FIBROMATOSIS; GENE; GENE ACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY DEVELOPMENT; NEPHROBLASTOMA; PRIORITY JOURNAL; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WT1 GENE;

ALTERNATIVE SPLICING; BETA CATENIN; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; EXONS; FIBROMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY; PLASMIDS; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION; WT1 PROTEINS;

EID: 19944433944     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20717     Document Type: Article

References (32)

1. Alman BA, Li C, Pajerski ME, Diaz-Cano S, Wolfe HJ. Increased β-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol 1997;151:329-34.
2. Tejpar S, Nollet F, Li C, Wunder JS, Michils G, dal Cin P, Van Cutsem E, Bapat B, van Roy F, Cassiman JJ, Alman BA. Predominance of β-catenin mutations and β-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 1999;18:6615-20.
3. Cheon SS, Cheah AY, Turley S, Nadesan P, Poon R, Clevers H, Alman BA. beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc Natl Acad Sci USA 2002;99:6973-8.
4. Morin PJ. Beta-catenin signaling and cancer. Bioessays 1999;21:1021-30.
5. Cadigan KM, Nusse R. Wnt signaling: a common theme in animal development. Genes Dev 1997;11:3286-305.
6. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-12.
7. Tejpar S, Li C, Yu C, Poon R, Denys H, Sciot R, Van Cutsem E, Cassiman JJ, Alman BA. Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour). Br J Cancer 2001;85:98-101.
8. Denys H, Jadidizadeh A, Amini Nik S, Van Dam K, Aerts S, Alman BA, Cassiman JJ, Tejpar S. Identification of IGFBP-6 as a significantly downregulated gene by beta-catenin in desmoid tumors. Oncogene 2004;23:654-64.
9. Maiti S, Alam R, Amos CI, Huff V. Frequent association of beta-catenin and WT1 mutations in Wilms' tumors. Cancer Res 2000;60:6288-92.
10. Koesters R, Ridder R, Kopp-Schneider A, Betts D, Adams V, Niggli F, Briner J, von Knebel Doeberitz M. Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors. Cancer Res 1999;59:3880-2.
11. Sim EU, Smith A, Szilagi E, Rae F, Ioannou P, Lindsay MH, Little MH. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1. Oncogene 2002;21:2948-60.
12. Davies JA, Ladomery M, Hohenstein P, Michael L, Shafe A, Spraggon L, Hastie N. Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation. Hum Mol Genet 2004;13:235-46.
13. Oji Y, Miyoshi S, Maeda H, Hayashi S, Tamaki H, Nakatsuka S, Yao M, Takahashi E, Nakano Y, Hirabayashi H, Shintani Y, Oka Y, et al. Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. Int J Cancer 2002;100:297-303.
14. Koesters R, Linnebacher M, Coy JF, Germann A, Schwitalle Y, Findeisen P, von Knebel Doeberitz M. WT1 is a tumor-associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cells. Int J Cancer 2004;109:385-92.
15. Stark K, Vainio S, Vassileva G, McMahon AP. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 1994;372:679-83.
16. Pritchard-Jones K, Fleming S, Davidson D. Bickmore W, Porteous D, Gosden C. Bard J, Buckler A, Pelletier J, Housman D, Van Heyningen V, Hastie ND. The candidate Wilms' tumour gene is involved in genitourinary development. Nature 1990;346:194-7.
17. Hartmann C, Tabin CJ. Dual roles of Wnt signaling during chondrogenesis in the chicken limb. Development 2000;127:3141-59.
18. Fukuzawa R, Heathcott RW, Sano M, Morison IM, Yun K, Reeve AE. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway. Pediatr Dev Pathol 2004;7:125-37.
19. Hastie ND. Life, sex, and WT1 isoforms: three amino acids can make all the difference. Cell 2001;106:391-4.
20. Haber DA, Sohn, RL, Buckler AJ, Pelletier J, Call KM, Housman DE. Alternative splicing and genomic structure of the Wilms' tumor gene WT1. Proc Natl Acad Sci USA 1991;88:9618-22.
21. Lee SB, Haber DA. Wilms' tumor and the WT1 gene. Exp Cell Res 2001;264:74-99.
22. Natoli TA, McDonald A, Alberta JA, Taglienti ME, Housman DE, Kreidberg JA. A mammal-specific exon of WT1 is not required for development or fertility. Mol Cell Biol 2002;22:4433-8.
23. Cohen HT, Bossone SA, Zhu G, McDonald GA, Sukhatme VP. Sp1 is a critical regulator of the Wilms' tumor-1 gene. J Biol Chem 1997;272:2901-13.
24. Dehbi M. Hiscott J, Pelletier J. Activation of the wt1 Wilms' tumor suppressor gene by NF-κB. Oncogene 1998;16:2033-9.
25. McConnell MJ, Cunliffe HE, Chua LJ, Ward TA, Eccles MR. Differential regulation of the human Wilms' tumour suppressor gene (WT1) promoter by two isoforms of PAX2. Oncogene 1997;14:2689-700.
26. Fraizer GC, Shimamura R, Zhang X, Saunders GF. PAX 8 regulates human WT1 transcription through a novel DNA binding site. J Biol Chem 1997;272:30678-87.
27. Rupprecht HD, Drummond IA, Madden SL, Rauscher FJ 3rd, Sukhatme VP. The Wilms' tumor suppressor gene WT1 is negatively autoregulated. J Biol Chem 1994;269:6198-206.
28. Ye Y, Raychaudhuri B, Gurney A, Campbell CE, Williams BR. Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation. EMBO J 1996;15:5606-15,
29. Rauscher FJ 3rd, Morris JF, Tournay OE, Cook DM, Curran T, Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 1990;250:1259-62.
30. Morris JF, Madden SL, Tournay OE, Cook DM, Sukhatme VP, Rauscher FJ 3rd. Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. Oncogene 1991;6:2339-48.
31. Hewitt SM, Hamada S, McDonnell TJ, Rauscher FJ 3rd, Saunders GF. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Cancer Res 1995;55:5386-9.
32. Ryan G, Steele-Perkins V, Morris JF, Rauscher FJ 3rd, Dressler GR. Repression of Pax-2 by WT1 during normal kidney development. Development 1995;121:867-75.